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Objectives: Fatigue is a highly subjective and extremely common symptom in patients with 
rheumatoid arthritis although it is difficult to characterize and define. The aim of this study 
was to assess fatigue in a cohort of Brazilian patients, and to analyze the relationship be-
tween fatigue and disease-specific variables.
Methods: 371 Brazilian patients diagnosed with rheumatoid arthritis according to the 1987 
American College of Rheumatology classification criteria were prospectively investigated. 
Demographic, clinical and laboratorial data were obtained from hospitals records. The 
number of painful joints, bone mass index, disease duration, quality of life, functional ca-
pacity, anxiety and depression were recorded. Fatigue was evaluated using the subscale of 
Fatigue Assessment of Chronic Illness Therapy (FACIT-FATIGUE scale).
Results: The median fatigue score was 42.0 (10.0), negatively correlated with functional ca-
pacity (-0.507; P < 0.001), anxiety and depression (-0.542 and -0.545; P < 0.001 respectively), 
and predominantly with physical domain of Short Form 36-item quality of life question-
naire (SF-36P: 0.584; P < 0.001). The scores were not associated with the erythrocyte sedi-
mentation rate (-0.118; P < 0.05), C-reactive protein (-0.089; P < 0.05), disease activity (-0.250; 
P < 0.001) or the number of painful joints (-0.135; P < 0.01). Confidence interval of 95% was 
applied for all measures.
Conclusions: In this series of Brazilian patients with rheumatoid arthritis, we suggest a new 
significance for fatigue complains as an independent parameter not related with number 
of painful joints, disease or inflammatory activity scores. Psychological and functional im-
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Análise da associação da fadiga com variáveis clínicas e psicológicas em 
uma série de 371 pacientes brasileiros com artrite reumatoide
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r e s u m o
Objetivos: A fadiga é um sintoma altamente subjetivo e extremamente comum em pacien-
tes com artrite reumatoide, embora seja difícil de caracterizar e definir. O objetivo desse 
estudo foi avaliar a fadiga em uma coorte de pacientes brasileiros e analisar a relação entre 
fadiga e variáveis específicas da doença.
Métodos: Foram prospectivamente investigados 371 pacientes brasileiros diagnosticados 
com artrite reumatoide, de acordo com os critérios de classificação do Colégio Americano 
de Reumatologia de 1987. Dados demográficos, clínicos e laboratoriais foram obtidos dos 
registros clínicos. Foram registrados o número de articulações dolorosas, índice de massa 
corporal, duração da doença, qualidade de vida, capacidade funcional, ansiedade e depres-
são. A fadiga foi avaliada com o uso da subescala específica da escala Fatigue Assessment of 
Chronic Illness Therapy (FACIT-FATIGUE).
Resultados: O escore mediano para fadiga foi 42 (10), negativamente correlacionado com a 
capacidade funcional (-0,507; p < 0,001), ansiedade e depressão (-0,542 e -0,545; p < 0,001, 
respectivamente) e predominantemente com o domínio físico do questionário Short Form-
36 para qualidade de vida (SF-36P: 0,584; p < 0,001). Não houve correlação entre os escores 
e a velocidade de sedimentação das hemácias (-0,118; p <0,05), proteína C reativa (-0,089; 
p < 0,05), atividade da doença (-0,250;p < 0,001) ou número de articulações dolorosas (-0,135; 
p < 0,01). Para todas as medidas foi aplicado um intervalo de confiança de 95%.
Conclusões: Nesta série de pacientes brasileiros com artrite reumatoide, sugerimos um novo 
significado para as queixas de fadiga como um parâmetro independente não relacionado 
com o número de articulações dolorosas ou escores de atividade inflamatória. Parece ha-
ver maior relação entre transtornos psicológicos e funcionais com a fadiga. Seriam impor-
tantes novos estudos e uso rotineiro de medidas padronizadas para a monitorização das 
queixas de fadiga.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
pairments appear to be more related to fatigue. Additional studies and inclusion of stan-
dard measures for monitoring fatigue complains are required. 
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
Introduction
Rheumatoid arthritis (RA) is a systemic inflammatory dis-
ease that can lead to significant morbidity, joint deformity 
and an impaired quality of life (QoL). This disease affects 
approximately 0.5%-1% of the general population, with con-
siderable variations being observed among different popula-
tions.1-3 Although the joints are the major loci of disease ac-
tivity, fatigue is a notably common and disabling symptom 
experienced almost universally by patients with RA (88%-
98%), who consider the effect and importance of fatigue 
similar to pain.4-9
There is no universally accepted definition of fatigue. It 
can be either defined as a progressive impairment of capac-
ity to generate muscle or a lessened capacity to work, with 
reduced efficiency of accomplishment, that are usually ac-
companied by feelings of weariness, sleepiness or irritabil-
ity.10 Belza et al. described fatigue as an “enduring the sub-
jective sensation of generalized tiredness or exhaustion”.11 
In the general population, 20% of men and 30% of women 
complain about frequent tiredness.12
Fatigue often accompanies various illnesses, and has 
been increasingly recognized and studied in a number of 
chronic diseases, such as liver disorders, infections and he-
matological diseases.12
Hewlett et al. observed that RA fatigue is a different phe-
nomenon from normal tiredness because it is extreme, end-
less and unresolved described as an important and over-
whelming complaint.4 Studies examining the predictive 
factors of fatigue in RA reported not only physical but also 
psychological and social aspects related to fatigue.4,13,14 Pain, 
physical disability, inactivity and poorer sleep quality and 
psychosocial factors, such as depressive symptoms, anxiety 
and social stress (as long-term symptoms or associated con-
ditions) are predictive of fatigue in RA.13,14
During the chronic course of RA, continuing inflamma-
tory activity with periods of prolonged physical inactivity 
leads to muscle atrophy and instability of the periarticular 
structures with reduced strength and muscular endurance 
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that contribute to the onset of fatigue. Ekdahl et al. dem-
onstrated that 80% of patients with RA exhibited changes 
in muscle strength and coordination of the lower extremi-
ties and decreased aerobic activity. These results were con-
firmed by Semble et al.15,16 In 1996, Rall et al. evaluated the ef-
fect of an exercise program to improve the muscle strength 
in patients with RA and observed a significant reduction in 
fatigue (38%).17
Due to fatigue’s multifactorial and multidimensional 
nature, this condition is difficult to assess. Little is known 
concerning the correlations, adequate measurements or the 
clinical management and interventions for fatigue.4,18 Persis-
tent fatigue is one of the most significant obstacles to opti-
mizing function in these patients.19
The aim of this study was to analyze aspects of fatigue 
in 371 Brazilian RA patients, and the association of fatigue 
with disease-specific variables, such as inflammatory ac-
tivity, pain, QoL, physical function, and psychological com-
plains, such as anxiety and depression.
Methods
A total of 371 patients with RA were recruited at the De-
partment of Rheumatology of Hospital da Santa Casa da 
Misericórdia do Rio de Janeiro (HSCMRJ) and Hospital Uni-
versitário Pedro Ernesto (HUPE) into this cross-sectional pro-
spective study from 2010-2011. Patients were between the 
ages of 18 and 65 years, diagnosed with RA according to the 
1987 American College of Rheumatology (ACR) RA classifica-
tion criteria.20 For all of the patients invited and included 
in the study written informed consents were provided. The 
research was conducted with approval by and in accordance 
with the Ethics Committee of both hospitals.
The patients who were unable to understand and re-
spond the questionnaires or who had any comorbidities 
that might interfere with the assessment of fatigue, such as 
anemia (hemoglobin > 9.0 mg/dl), endocrine diseases (diabe-
tes type I and II, thyroid diseases), renal failure (creatinine 
< 2.0mg/dl), liver diseases including cirrhosis, pulmonary 
(Chronic Obstructive Pulmonary Disease) or cardiovascular 
disorders, were excluded.
Demographic and clinical data were collected including 
duration of disease, number of painful peripheral joints and 
body mass index (BMI). Disease activity was clinically mea-
sured, using the 28 joint count Disease Activity Score (DAS 
28), and biologically, using the erythrocyte sedimentation 
rate (ESR) and C-reactive protein (CRP) levels.
Physical function was assessed by the Health Assess-
ment Questionnaire-Disability Index (HAQ DI), where scores 
range from 0 to 3, and higher scores indicate lower levels 
of physical functioning.21,22 The health-related quality of life 
(HRQol) was assessed using physical and mental scores of 
the Short-Form 36-Items Health Survey (SF-36P and SF-36M) 
generic questionnaire.23
The Hospital Anxiety and Depression Scale (HAD a/d) was 
used to evaluate the depression and anxiety symptoms. This 
questionnaire has 14 interlaced questions: one-half of the 
questions were related to anxiety, and one-half to depres-
sion. For each question, a value from 0 to 3 is added to each 
domain separately, building the two sub-scales. Patients 
with results greater than 8 are considered at risk of anxiety 
and/or depression independently.12 All questionnaires used 
were validated and culturally adapted to the Portuguese lan-
guage.12,21–23
Fatigue was evaluated using a subscale of the Functional 
Assessment of Chronic Illness Therapy (FACIT), which was 
initially validated to assess QoL in patients with cancer or 
other chronic illnesses. The scale was used for RA patients, 
who only scores the fatigue complains (FACIT-Fatigue). The 
total score ranges from 0 to 52, and higher scores represent 
less fatigue.24 The FACIT-Fatigue was validated for Portu-
guese version through an authorization from the site http://
www.facit.org. 
Statistical analysis
Calculating the minimum patient number with precision 
measurements estimated under parameters of 90% with 
confidence interval of 0.20 and α = 0.05, we got a minimum 
sample size of 258 patients.
Considering that both departments of Rheumatology 
treat approximately 800 patients with RA per year, 30%-40% 
of which fulfill the inclusion/exclusion criteria, the sample 
size could be about 240 to 320 patients.
Taking into account also that the fatigue complains could 
be present in 25% to 60% of RA patients,4,5,10,18,20,25,26,27 we 
found a sample size of 200 to 480 of those hospital’s popula-
tions.
We decided to establish a final sample size between 320 
to 480 patients. After two years of recruitment, 371 patients 
with useful data were finely included in this study.
All data were tested for normality by applying the Sha-
piro-Wilk Test. As all variables showed non-normal distri-
bution, the variables were presented by median (interquar-
tile range). Spearman’s rank correlation coefficient (rs) was 
calculated to determine correlations between fatigue and 
clinical or psychological measures. All tests were 2-sided, 
and P values ≤ 0.05 were considered statistically significant. 
Statistical analysis was performed using Statistica software, 
version 8.0 (Statsoft. Inc. Tulsa, USA).
Results
A total number of 371 patients were evaluated. The group 
studied included 335 women (90.3%) and 36 men (9.7%). The 
demographic and clinical data, which are summarized in 
Table 1, indicated the majority of our patients were white 
(66.8%), followed by mixed-race patients (20.5%), and black 
patients (12.7%). The median age was 51 (13) years and the 
BMI was 25.0 (3.6). The mean score of fatigue (FACIT–Fatigue) 
was 42.0 (10), and the mean number of painful joints was 6 
(6). The median disease duration was 6 (6) years.
The median disease activity, as assessed by DAS 28, was 
4.7 (2). The median ESR was 33 (27) mm, and the median of 
CRP level was 0.8 (1.7).
When the DAS 28 cut-off values for measuring inflamma-
tory disease activity were applied, 7.0% of the patients were 
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in remission (DAS 28 < 2.6), 7.8% had lower disease activity 
(DAS 28 ≥ 2.6 ≤ 3.2), 9.7% had moderate disease activity (DAS 
28 ≥ 3.2 ≤ 5.1), and 75.5% of the sample had high disease 
activity (DAS 28 > 5.1).
The median score of the SF-36 was 87.5 (12.2). The means 
of the physical and mental subscales were 39.1 (10.5) and 
47.6 (11.0), respectively. The mean of the HAQ DI was 1.0 
(0.7). The anxiety and depression questionnaire (HAD a/d) 
showed means of 7.0 (3.4) for anxiety, and 5.4 (3.6) for de-
pression, respectively.
The distribution of disease activity (DAS 28) and duration 
of illness (years) in this sample of RA patients are shown in 
Fig. 1.
The correlations between fatigue (FACIT-Fatigue), quality 
of life (SF-36), functional capacity (HAQ DI), painful joints, 
anxiety and depression (HAD a/d), DAS 28, ESR and CRP are 
shown in Table 2. The correlations of fatigue with QoL, anxi-
ety and depression or functional capacity are shown in the 
graphs of Figs. 2 and 3.
Table 3 presents the correlations of fatigue with disease 
activity measured by ESR, CRP and DAS 28 and the QoL by 
the physical and mental domains of SF-36 (SF-36P and SF-
36M), functional capacity by HAQ DI, the number of painful 
joints, and anxiety or depression as measured by HAD a/d 
in patients with moderate and high disease activity (DAS 28 
≥ 3.2). 
Discussion 
This study was the fi rst in our country to analyze a sam-
ple of 371 Brazilian patients with RA, assessing fatigue by 
FACIT-Fatigue, a 13-items measure of fatigue that previously 
showed good internal consistency in patients with RA.
In recent years, fatigue has emerged as an important 
outcome in RA,4,8,13,14 although the symptoms are largely ig-
nored in terms of clinical care and educational and research 
endeavours. The multifactorial and multidimensional char-
acteristics of fatigue demand a broad analysis that takes 
into consideration the clinical, cultural and social aspects of 
fatigue complaints and includes the patient’s perspective. In 
Rio de Janeiro, a cosmopolitan coastal city, the mixed popu-
lation and the tropical climate with a majority of sunny days 
could modify the perception of fatigue and its correlation to 
the indices of disease activity, QoL, functional capacity, pain, 
anxiety and depression. 
Cella D et al. validated the FACIT-Fatigue, comparing it 
to other scales such as the Multidimensional Assessment 
of Fatigue (MAF) and the SF-36 in 636 patients with RA for 
24 weeks in a double blind, randomized trial using anti-TNF 
Table 1 – Baseline characteristics of RA patients (n = 371)
Characteristics Mean (sd) or n (%) Median Min Max - CI 95% + CI 95%
Women 335 (90.3)
Ethnic group
White 248 (66.8)
Mixed-race 76 (20.5)
Black 47 (1.7)
Age 49.5 (10.2) 51.0 18.0 65.0 48.6 50.7
BMI 25.2 (3,9) 25.0 16.3 43.9 24.8 25.6
Disease duration (year) 7.8 (5,8) 6.0 1.0 43.0 7.2 8.4
Laboratory assessment of disease activity
ESR 36.2 (22.7) 33.0 2.0 118.0 33.9 38.5
CRP 1.8 (3.2) 0.8 0.1 33.5 1.5 2.2
Clinical assessments
DAS 28 4.6 (1.4) 4.7 0.0 8.1 4.4 4.7
HAQ DI 1.0 (0.7) 0.8 0.0 2.8 0.9 1.0
SF-36 86.9 (8.5) 87.5 51.0 99.6 86.0 87.7
Physical domain 39.1 (10.5) 39.5 12.1 68.3 38.1 40.2
Mental domain 47.6 (11.0) 50.1 12.4 96.1 46.5 48.8
HAD a 7.0 (3.4) 7.0 0.0 20.0 6.7 7.4
HAD d 5.4 (3.6) 5.0 0.0 20.0 5.0 5.7
FACIT-Fatigue 39.9 (8.6) 42.0 4.0 52.0 39.0 40.8
Number of Painfull joints 6.83(4.78) 6.0 0.0 28.0 6.4 7.3
BMI: Bone Mass Index, ESR: Erythrocyte Sedimentation Rate, CRP: C Reactive Protein, DAS 28: 28 Disease Activity Index, HAQ DI: Health 
Assessment Questionnaire Disability Index, SF-36: Short-Form 36-item, HAD a/d: Hospital Anxiety and Depression Scale, FACIT-Fatigue: Fatigue 
Assessment of Chronic Illness Therapy.
Fig. 1 – Distribution of disease duration with disease 
activity by DAS28 and number of patients.
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Fig. 3 – Spearman’s correlations coefficient between FACIT 
fatigue and HAD a (A) and HAD d (B).
Fig. 2 – Spearman’s correlations coefficient between FACIT 
fatigue and SF-36 (A) and HAQ DI (B).
Table 2 – Analysis of Spearman’s correlations coefficient of all patients 
ESR CRP SF36-P SF36-M HAD-a HAD-d DAS28 HAQ-DI Facit fatigue Painful joints
ESR  0.467* -0.203* -0.161*  0.101  0.130*  0.472*  0.190* -0.118*  0.220*
CRP  0.467* -0.191* -0.024  0.072  0.103*  0.356*  0.189* -0.089  0.203*
SF-36P -0.203* -0.191*   0.121* -0.328* -0.406* -0.439* -0.672*  0.584* -0.293*
SF-36M -0.161* -0.024  0.121* -0.477* -0.437* -0.131* -0.175*  0.405* -0.019
HAD a  0.101  0.072 -0.328* -0.477*  0.648*  0.169*  0.294* -0.542*  0.060
HAD d  0.130*  0.103* -0.406* -0.437*  0.648*  0.244*  0.347* -0.545*  0.101*
DAS 28  0.472*  0.356* -0.439* -0.131*  0.169*  0.244*  0.356* -0.250*  0.725*
HAQ DI  0.190*  0.189* -0.672* -0.175*  0.294*  0.347*  0.356* -0.507*  0.219*
Facit fatigue -0.118* -0.089  0.584*  0.405* -0.542* -0.545* -0.250* -0.507* -0.135*
Painful joints  0.220*  0.203* -0.293* -0.019  0.060  0.101*  0.725*  0.219* -0.135*
ESR: Erythrocyte Sedimentation Rate, CRP: C-Reactive protein, SF-36: Short-Form 36-item, SF-36P: Short-Form 36-item Physical domain, SF-36M: 
Short-Form 36-item Mental domain, HAD a: Hospital Anxiety Scale, HAD d: Hospital Depression Scale, DAS28: Disease Activity Score, HAQ DI: 
Health Assessment Questionnaire – Disability Index, and FACIT fatigue: Fatigue Assessment of Chronic Illness Therapy. *Statistically significant 
(p < 0.05).
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alpha monoclonal antibody and placebo, where the psycho-
metric performance of the FACIT-Fatigue scale for assess-
ment of fatigue was comparable to the other scales.24
The demographic findings of gender and ethnicity are 
similar to previous reports, which indicate a female and 
white predominance, reflecting the typical incidence of RA 
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patients. These results differ in ethnic characteristics of 
Brazilian population, in which 47.7% are white according 
to data from the Brazilian Institute of Geography and Sta-
tistics (IBGE).28
The disease duration was under 10 years, and for the 
largest number of patients there had been less than 5 years 
since symptoms onset and diagnosis confirmation. The 
mean disease activity quantified by DAS 28 score of 4.6, 
shown in Table 1, confirms that most of our cohort exhibit 
moderate or high disease activity.
Based on our findings, fatigue did not correlate with dis-
ease activity. As shown in Table 2, the FACIT-Fatigue has not 
demonstrated correlation with CRP, ESR and DAS 28, which 
are routinely evaluated as inflammatory disease activity 
indexes. The FACIT- Fatigue demonstrated a moderate cor-
relation with functional capacity (HAQ DI), as shown in Fig. 
2B, Table 2; anxiety and depression (HAD a/d), shown in Fig. 
3, and predominantly with the physical domain of quality 
of life (SF-36P), shown in Fig. 2A. 
A similar analysis with moderate and high disease activ-
ity (DAS 28 > 3.2) subgroups of this sample confirmed the 
absence of a correlation between fatigue and disease activi-
ty, shown in Table 3. This finding is in accordance with Huy-
ser et al., who suggested that fatigue in RA is not related to 
disease activity and showed that many of the variables that 
were significantly correlated with fatigue had a psychoso-
cial basis.25 Such factors, as anxiety and higher depressive 
symptoms, were significantly associated with increased 
fatigue, as was seen in this study (Fig. 3). The best predic-
tors of fatigue were higher levels of pain, more depressive 
symptoms and female gender, which were independent 
of disease activity.25 Our study showed that the number of 
painful joints, measured by the first item of DAS 28, did not 
correlate with fatigue independently of the level of pain or 
the patient global assessment.
Bergman et al. showed that fatigue is not an inflamma-
tory variable and has virtually no correlation with the num-
ber of swollen or tender joints. These researchers showed 
a moderate association of fatigue with DAS 28, and 79% of 
the complaints could be explained by the patient global as-
sessment.29
Yacoub et al. assessed fatigue in 248 patients with RA, 
finding a prevalence of fatigue in approximately 90% and, 
in contrast to our results, a significant association with dis-
ease activity.30 Thyberg et al. suggested that disease activity 
is among the factors closely related to fatigue.31
This study, using the HAD a/d scale, determined a corre-
lation between fatigue and emotional aspects, such as de-
pression and anxiety, shown in Fig. 3 and Table 2, which was 
reported by Huyser et al. Depression is a frequent complaint 
associated with fatigue in RA patients with a prevalence 
of 13%-20%, which is 2 to 3 times higher than observed in 
healthy people.25,32,33 The presence of pain, joint swelling 
and deformities, as well as functional disabilities and work 
or leisure restrictions in RA patients, could explain the 
higher number of depression cases. Functional disabilities 
result in reduction of self-confidence and QoL, leading to 
a depressive mood. Several authors attempted to correlate 
depression, anxiety and fatigue.25,34-36 Tack et al. found that 
in the RA population, higher fatigue was strongly associ-
ated with depressive symptoms, pain, and poorer overall 
mood.36 A recent study by Munsterman et al. confirms ear-
lier results that depressive symptoms are associated with 
fatigue.27
We observed a moderate correlation of fatigue with QoL 
(SF-36) and functional capacity (HAQ DI), as presented in 
Fig. 2. Yacoub et al. report that fatigue was significantly as-
sociated with functional disability.30 Pollard et al. found sim-
ilar results with a significant relationship between fatigue 
and functional disability, suggesting that severe fatigue had 
a negative impact on patients QoL.37 Thyberg et al. suggest 
that fatigue is related to physical aspects of disability such 
as pain, activity limitation and mental aspects, which may 
be a psychological reaction to physical disability.31 Each of 
these studies measures fatigue by different questionnaires, 
scales and methods, achieving results that are not directly 
comparable. 
Regarding the application of FACIT–Fatigue as a specific 
instrument of fatigue evaluation in RA patients, these data 
showed consistency and significant correlation with other 
protocols (SF-36, HAD a/d, HAQ DI) demonstrated in Figs. 
2 and 3, with significant values being observed in Table 2. 
These findings indicate that patient’s complaint of fatigue 
is an independent data in the analysis of disease evolution.
We suggest a new significance for fatigue complaints in 
RA patients, which is an independent parameter that is not 
related to inflammatory activity. Fatigue appears to be re-
lated to the physical capacity and emotional symptoms as-
sociated with the negative effect of disability on the quality 
of life of some patients. Reports in the literature are con-
flicting, most likely because of the multifactorial etiology of 
fatigue and its correlation with physiological, psychologi-
cal, social, personal and individual disease aspects, as well 
as the non-existence of a standardized evaluation method. 
These results emphasize the need for a better understand-
ing of fatigue in RA patients with additional studies and an 
inclusion of standard measures for monitoring the symp-
toms and clinical management of fatigue. As recently rec-
ommended by OMERACT, psychological and psychosocial 
interventions, taking into account considerations that the 
Table 3 – Analysis of Spearman’s correlations coefficient of patients with high and moderate disease activity (n = 316) 
n = 316 ESR CRP SF-36P SF36M HAD a HAD d DAS 28 HAQ DI Painful joints
Facit-fatigue -0.108 -0.065 0.577* 0.456* -0.539* -0.528* -0.218* -0.489* -0.080
ESR: Erythrocyte Sedimentation Rate, CRP: C Reactive Protein, SF36P: Short-Form 36-Item Physical domain, SF-36M: Short-Form 36-Item Mental 
domain, HAD a: Hospital Anxiety and Depression Scale-anxiety domain, HAD d: Hospital Anxiety and Depression Scale-depression domain, 
DAS 28: Disease Activity Score, HAQ DI: Health Assessment Questionnaire Disability Index, and FACIT fatigue: Fatigue Assessment of Chronic 
Illness Therapy. *Statistically significant (p < 0.001).
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patient’s perspective should be considered in studies and 
clinical practice to improve the results of treatment of fa-
tigue.38
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